Alto Neuroscience, Inc.ANRONYSE
Loading
Operating Expenses Over TimeStrong
Percentile Rank75
3Y CAGR+31.6%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+31.6%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$65.70M-3.5%
2024$68.11M+80.1%
2023$37.81M+31.1%
2022$28.85M+138.0%
2021$12.12M-